Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2026-01-02 @ 5:03 AM
Study NCT ID:
NCT02322866
Status:
COMPLETED
Last Update Posted:
2019-02-01
First Post:
2014-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
Sponsor:
Almirall, S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-03
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-15
First Submit QC Date:
None
Study First Post Date:
2014-12-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-03
Results First Submit QC Date:
None
Results First Post Date:
2018-05-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-31
Last Update Post Date:
2019-02-01
Last Update Post Date Type:
ACTUAL